Effect of an age-mismatched and sex-mismatched normal database on the diagnostic performance of 18F-FDG PET for Alzheimer's disease: The Ishikawa Brain Imaging Study

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1128-1133

  Chen, Wei Ping ^a   Samuraki, Miharu ^b   Shima, Keisuke ^b   Yanase, Daisuke ^b   Takeda, Nozomi ^a   Miyazaki, Yoshiharu ^a   Ono, Kenjiro ^b   Yoshita, Mitsuhiro ^b   Nishimura, Shintaro ^a   Yamada, Masahito ^b   Matsunari, Ichiro ^a  

^a Medical and Pharmacological Research Center Foundation   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

18F FDG PET; Alzheimer's disease; effect of age and sex; normal database

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DATA COLLECTION; DATABASES, FACTUAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEX FACTORS; YOUNG ADULT;

EID: 80455173823     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834b43c2     Document Type: Article

References (22)

1. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17:302-316.
2. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42:85-94.
3. Petrella J, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003; 226:315-336.
4. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36:1238-1248.
5. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2:189-210.
6. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 1999; 9:63-80.
7. Fujimoto T, Matsumoto T, Fujita S, Takeuchi K, Nakamura K, Mitsuyama Y, et al. Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain. Psychiatry Res 2008; 16:58-72.
8. Kawachi T, Ishii K, Sakamoto S, Matsui M, Mori T, Sasaki M. Gender differences in cerebral glucose metabolism: a PET study. J Neurol Sci 2002; 199:79-83.
9. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995; 36:1141-1149.
10. Willis MW, Ketter TA, Kimbrell TA, George MS, Herscovitch P, Danielson AL, et al. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Res 2002; 114:23-37.
11. Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, et al. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging 2005; 32:794-805.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
13. Berg L. Clinical dementia rating. Br J Psychiatry 1984; 145:339.
14. Bergström M, Eriksson L, Bohm C, Blomqvist G, Litton J. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 1983; 7:42-50.
15. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35:1398-1406.
16. Nowinski WL, Fang A, Nguyen BT, Raphel JK, Jagannathan L, Raghavan R, et al. Multiple brain atlas database and atlas-based neuroimaging system. Comput Aided Surg 1997; 2:42-66.
17. Matsunari I, Samuraki M, Chen WP, Yanase D, Takeda N, Ono K, et al. Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance. J Nucl Med 2007; 48:1961-1970.
18. Chen WP, Samuraki M, Yanase D, Shima K, Takeda N, Ono K, et al. Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis. Nucl Med Commun 2008; 29:270-276.
19. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007; 48:1289-1300.
20. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis. Generalization to the population of readers and patients with the jackknife method. Invest Radiol 1992; 27:723-731.
21. Chen W, Matsunari I, Noda A, Yanase D, Yajima K, Takeda N, et al. Rapid scanning protocol for brain (18)F-FDG PET: a validation study. J Nucl Med 2005; 46:1633-1641.
22. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 1996; 10:180-188.